arrow
M

Michał Ordak

Medical University of Bialystok
H指数:29
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

As-Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK-air Study

花粉季节过敏性鼻炎治疗中按需用药与常规用药的比较:一项MASK-air研究

2026-09-100
OAAI
Trace Elements in Allergy: Narrative Review

过敏中的微量元素:叙事性综述

2026-05-040
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第II部分—口服和眼部治疗指南

2026-03-240
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第一部分—关于鼻内治疗的指南

2025-12-010
OAAI
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms

过敏性鼻炎及其对哮喘的影响(ARIA)-EAACI 2024–2025指南的开发方法:从证据到决策框架到数字化共享决策算法

2025-11-210
OAAI
Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data

基于移动健康数据,采用目标试验模拟方法评估过敏性鼻炎药物的有效性

2025-11-010
OAAI
Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report

过敏性鼻炎治疗对患者满意度的影响比较:一项MASK-air和EAACI方法学委员会报告

2025-09-260
OAAI